Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weldon

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Vaccine|April 30, 2017
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin AmericaEduardo Lopez-Medina, Mario Melgar, James T Gaensbauer, et al.
Journal of Medicinal Chemistry|May 31, 2002
1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic propertiesEdwin B Villhauer, John A Brinkman, Goli B Naderi, et al.
Rapid Communications in Mass Spectrometry : RCM|January 14, 2020
Protocol for community-created public MS/MS reference spectra within the Global Natural Products Social Molecular Networking infrastructureFernando Vargas, Kelly C Weldon, Nicole Sikora, et al.
Anesthesiology|August 1, 1996
Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study GroupS Khalil, A Rodarte, B C Weldon, et al.
The Lancet. Infectious Diseases|December 7, 2020
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialAnanda S Bandyopadhyay, Chris Gast, Luis Rivera, et al.
The Journal of Infectious Diseases|February 16, 2006
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulinJaap Goudsmit, Wilfred E Marissen, William C Weldon, et al.
Vaccine|January 22, 2020
Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccineJordan A Stinson, Carter R Palmer, David P Miller, et al.
Vaccine|February 25, 2020
Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patientsSharla L McDonald, William C Weldon, Ling Wei, et al.
Plos One|July 26, 2022
Non-invasive skin sampling detects systemically administered drugs in humansMorgan Panitchpakdi, Kelly C Weldon, Alan K Jarmusch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2010
Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virusIoanna Skountzou, Dimitrios G Koutsonanos, Jin Hyang Kim, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Vaccine|April 30, 2017
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin AmericaEduardo Lopez-Medina, Mario Melgar, James T Gaensbauer, et al.
Journal of Medicinal Chemistry|May 31, 2002
1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic propertiesEdwin B Villhauer, John A Brinkman, Goli B Naderi, et al.
Rapid Communications in Mass Spectrometry : RCM|January 14, 2020
Protocol for community-created public MS/MS reference spectra within the Global Natural Products Social Molecular Networking infrastructureFernando Vargas, Kelly C Weldon, Nicole Sikora, et al.
Anesthesiology|August 1, 1996
Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study GroupS Khalil, A Rodarte, B C Weldon, et al.
The Lancet. Infectious Diseases|December 7, 2020
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trialAnanda S Bandyopadhyay, Chris Gast, Luis Rivera, et al.
The Journal of Infectious Diseases|February 16, 2006
Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulinJaap Goudsmit, Wilfred E Marissen, William C Weldon, et al.
Vaccine|January 22, 2020
Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccineJordan A Stinson, Carter R Palmer, David P Miller, et al.
Vaccine|February 25, 2020
Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patientsSharla L McDonald, William C Weldon, Ling Wei, et al.
Plos One|July 26, 2022
Non-invasive skin sampling detects systemically administered drugs in humansMorgan Panitchpakdi, Kelly C Weldon, Alan K Jarmusch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2010
Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virusIoanna Skountzou, Dimitrios G Koutsonanos, Jin Hyang Kim, et al.
Pageof 16